These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37797524)

  • 1. Oesophageal pH capsule retention: case report and proposed endoscopic management.
    Alshareefy Y; Alshareefy A
    Int J Surg Case Rep; 2023 Oct; 111():108917. PubMed ID: 37797524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
    Gallusi G; Pontone S
    Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoluminal therapies for gastro-oesophageal reflux disease.
    Galmiche JP; Bruley des Varannes S
    Lancet; 2003 Mar; 361(9363):1119-21. PubMed ID: 12672327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
    Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield of prolonged wireless pH monitoring in achalasia patients successfully treated with pneumatic dilation.
    Mauro A; Franchina M; Elvevi A; Pugliese D; Tenca A; Conte D; Penagini R
    United European Gastroenterol J; 2017 Oct; 5(6):789-795. PubMed ID: 29026592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve months' follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study.
    Montgomery M; Håkanson B; Ljungqvist O; Ahlman B; Thorell A
    Scand J Gastroenterol; 2006 Dec; 41(12):1382-9. PubMed ID: 17101568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of gastro-oesophageal reflux in children.
    Tighe MP; Andrews E; Liddicoat I; Afzal NA; Hayen A; Beattie RM
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD008550. PubMed ID: 37635269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of twenty-four hour intraoesophageal pH monitoring and manometry in the management of patients with upper gastrointestinal symptoms].
    Lakner L; Döbrönte Z
    Orv Hetil; 2009 Oct; 150(43):1978-82. PubMed ID: 19812019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
    Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
    Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic day case antireflux radiofrequency (Stretta) therapy improves quality of life and reduce proton pump inhibitor (PPI) dependency in patients with gastro-oesophageal reflux disease: a prospective study from a UK tertiary centre.
    Viswanath Y; Maguire N; Obuobi RB; Dhar A; Punnoose S
    Frontline Gastroenterol; 2019 Apr; 10(2):113-119. PubMed ID: 31205650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule.
    Eliakim R; Yassin K; Shlomi I; Suissa A; Eisen GM
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1083-9. PubMed ID: 15569110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up.
    Mahmood Z; McMahon BP; Arfin Q; Byrne PJ; Reynolds JV; Murphy EM; Weir DG
    Gut; 2003 Jan; 52(1):34-9. PubMed ID: 12477756
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.